Ivermectin does not reduce risk of severe illness from COVID-19: Malaysia study
by Press Release from Outbreak News Today on (#5RH39)
NewsDesk @bactiman63 The Institute for Clinical Research (ICR) NIH today announced findings for the Ivermectin study (I-TECH) in 500 hospitalised patients with Stage 2 or 3 COVID-19. This multi-centre open-label randomised controlled trial evaluated a 5-day course of ivermectin (0.4mg/kg/day) plus standard of care (IVM group), compared to standard of care (SOC group) according to Ministry [...]
The post Ivermectin does not reduce risk of severe illness from COVID-19: Malaysia study appeared first on Outbreak News Today.